R. A. Nelson, A. M. Levine, L. Bernstein, D. D. Smith, and L. L. Lai, Changing patterns of anal canal carcinoma in the United States, J Clin Oncol, vol.31, pp.1569-75, 2013.

A. Bouvier, A. Belot, and S. Manfredi, Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France
URL : https://hal.archives-ouvertes.fr/hal-01442356

, Eur J Cancer Prev, vol.25, pp.182-189, 2016.

C. De-martel, M. Plummer, J. Vignat, and S. Franceschi, Worldwide burden of cancer attributable to HPV by site, country and HPV type, Int J Cancer, vol.141, issue.4, pp.664-70, 2017.

L. C. Cajas-monson, S. L. Ramamoorthy, and B. C. Cosman, Expectant management of high-grade Anal dysplasia in people with HIV: long-term data, Dis Colon Rectum, vol.61, pp.1357-63, 2018.

G. C. Lee, H. Kunitake, and H. Milch, What is the risk of anal carcinoma in patients with anal intraepithelial neoplasia III?, Dis Colon Rectum, vol.61, pp.1350-1356, 2018.

S. Pernot, P. Boucheron, and H. Péré, Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men, Br J Canc, vol.119, pp.381-387, 2018.

E. Jeannot, V. Becette, and M. Campitelli, Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma, J Pathol Clin Res, vol.2, pp.201-210, 2016.

Z. Kang, . Stevanovi-c-s, C. S. Hinrichs, and L. Cao, Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring, Clin Cancer Res, vol.23, pp.6856-62, 2017.

G. Perkins, H. Lu, F. Garlan, and V. Taly, Droplet-based digital PCR, Advances in clinical chemistry, pp.43-91, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02299530

V. Taly, D. Pekin, A. Abed, L. El, and P. , Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02299585

L. Cabel, E. Jeannot, and I. Bieche, Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma, Clin Cancer Res, vol.24, pp.5767-71, 2018.

A. Bernard-tessier, E. Jeannot, and G. David, Clinical validity of HPV circulating tumor DNA in advanced anal carcinoma: an ancillary study to the Epitopes-HPV02 trial, Clin Cancer Res, 2018.

L. Cabel, F. Bidard, and V. Servois, HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: a case report, Int J Cancer, vol.141, issue.8, pp.1667-70, 2017.